These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 23413907)
1. Vaccine strategies for glioblastoma: progress and future directions. Jackson C; Ruzevick J; Brem H; Lim M Immunotherapy; 2013 Feb; 5(2):155-67. PubMed ID: 23413907 [TBL] [Abstract][Full Text] [Related]
2. Cancer vaccines: an update. Hipp JD; Hipp JA; Lyday BW; Minev BR In Vivo; 2000; 14(5):571-85. PubMed ID: 11125541 [TBL] [Abstract][Full Text] [Related]
3. Immunotherapy offers a promising bet against brain cancer. Eisenstein M Nature; 2018 Sep; 561(7724):S42-S44. PubMed ID: 30258155 [No Abstract] [Full Text] [Related]
4. Should dendritic cell-based tumor vaccination be incorporated into standard therapy for newly diagnosed glioblastoma patients? Van Gool S; De Vleeschouwer S Expert Rev Neurother; 2012 Oct; 12(10):1173-6. PubMed ID: 23082731 [No Abstract] [Full Text] [Related]
6. The development of dendritic cell vaccine-based immunotherapies for glioblastoma. Reardon DA; Mitchell DA Semin Immunopathol; 2017 Feb; 39(2):225-239. PubMed ID: 28138787 [TBL] [Abstract][Full Text] [Related]
7. Tumour vaccine approaches for CNS malignancies: progress to date. Ebben JD; Rocque BG; Kuo JS Drugs; 2009; 69(3):241-9. PubMed ID: 19275269 [TBL] [Abstract][Full Text] [Related]
8. Challenging Hurdles of Current Targeting in Glioblastoma: A Focus on Immunotherapeutic Strategies. Genoud V; Migliorini D Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33800593 [TBL] [Abstract][Full Text] [Related]
9. Heat shock protein-peptide complex in the treatment of glioblastoma. See AP; Pradilla G; Yang I; Han S; Parsa AT; Lim M Expert Rev Vaccines; 2011 Jun; 10(6):721-31. PubMed ID: 21692695 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of dendritic cell vaccines for patients with glioblastoma: A meta-analysis of randomized controlled trials. Lv L; Huang J; Xi H; Zhou X Int Immunopharmacol; 2020 Jun; 83():106336. PubMed ID: 32213460 [TBL] [Abstract][Full Text] [Related]
12. Heat shock protein vaccines against glioblastoma: from bench to bedside. Ampie L; Choy W; Lamano JB; Fakurnejad S; Bloch O; Parsa AT J Neurooncol; 2015 Jul; 123(3):441-8. PubMed ID: 26093618 [TBL] [Abstract][Full Text] [Related]
13. Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End. Datsi A; Sorg RV Front Immunol; 2021; 12():770390. PubMed ID: 34795675 [TBL] [Abstract][Full Text] [Related]
15. Vaccination in the immunotherapy of glioblastoma. Kong Z; Wang Y; Ma W Hum Vaccin Immunother; 2018 Feb; 14(2):255-268. PubMed ID: 29087782 [TBL] [Abstract][Full Text] [Related]
16. Rindopepimut: a promising immunotherapeutic for the treatment of glioblastoma multiforme. Swartz AM; Li QJ; Sampson JH Immunotherapy; 2014; 6(6):679-90. PubMed ID: 25186601 [TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for Glioblastoma: Current Progress and Challenges. Yu MW; Quail DF Front Immunol; 2021; 12():676301. PubMed ID: 34054867 [TBL] [Abstract][Full Text] [Related]
18. Current status and future applications of cellular therapies for cancer. Copier J; Bodman-Smith M; Dalgleish A Immunotherapy; 2011 Apr; 3(4):507-16. PubMed ID: 21463192 [TBL] [Abstract][Full Text] [Related]